Wilmer Cutler Pickering Hale and Dorr represented Trevi Therapeutics, Inc. in the offering, and Covington & Burling represented the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a...
Trevi Therapeutics’ $50 Million Common Stock Offering
Karyopharm’s Refinancing Transactions and Amended Royalty Agreement
Wilmer Cutler Pickering Hale and Dorr advised Karyopharm Therapeutics Inc. on the transactions. Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...